Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NICE

Nice fans ‘punch and spit’ at own players after sixth straight defeat

The Ligue 1 side slipped to their sixth straight loss on Sunday

The Independent UK

Manchester United owner Sir Jim Ratcliffe's other club in crisis after shocking attack: report

OGC Nice players Jeremie Boga and Terem Moffi were reportedly racially abused by members of the club's ultras

FourFourTwo

Cancer treatment that allows patients to avoid surgery given approval for NHS use

IN FULL

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The Fastest Tariff U-Turn in History: How Britain Made Trump Blink on Pharmaceuticals

Fastest tariff reversal ever: Britain wins zero-tariff pharma deal as Trump backs down—NHS faces 25% higher drug costs. See effects on patients and jobs.

International Business Times UK

New cancer treatment could prevent patients needing ‘devastating’ surgery

The treatment, known as Papillon, could allow patients with rectal cancer to avoid the need for a stoma

The Independent UK

Ghana World Cup 2026 squad: the Black Stars' latest selection for the March international break

The Ghana World Cup 2026 squad is coming together but a change in the dugout has disrupted preparations

FourFourTwo

The new asthma treatment that could ‘transform lives’

The injection is recommended as an additional maintenance treatment for patients over 12 when usual medications have not proven effective enough

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?

The U.K.’s National Institute for Health and Care Excellence (NICE) published on Tuesday draft guidance recommending Autolus Therapeutics plc’s (NASDAQ:AUTL) Aucatzyl (obecabtagene autoleucel, or obe-cel) for use in the National Health Service (NHS) for adult patients (≥26 years) with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL).

Benzinga

‘Next generation’ treatment to cure leukaemia given NHS approval

‘The biggest thing it offers is hope,’ says patient involved in clinical trial which cured cancer in significant portion of leukaemia sufferers

The Independent UK

Health benefits of Mounjaro reverse when jabs halted, study says

Researchers found benefits including reduced blood pressure were reversed after patients ceased taking the jab

The Independent UK

‘Important moment’ as at-home heart treatment approved for NHS use

About 1,500 patients in England and Wales live with the rare heart condition

The Independent UK

Prozac ‘no better than placebo’ for treating children with depression, experts say

Exclusive: Clinical guidelines should change to avoid exposing young people to potentially harmful side-effects, researchers say

The Guardian - UK

Now AI will be used to help NHS doctors spot pre-cancerous growths

The technology will be used to spot early signs of bowel cancer

The Independent UK

Congressman Buys Shares Of Small AI Company You've Probably Never Heard Of

Many people around the world have made investments in artificial intelligence stocks over the last year. When a member of Congress buys shares of a $7 billion AI-related company, investors likely take notice.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

NICE Just Showed Why Its AI-First Strategy Is Winning

NICE Ltd (NASDAQ:NICE) shares rose Thursday after the company reported its third-quarter results, beating street estimates.

MarketBeat

3 Beaten-Down Stocks With Rebound Potential This Earnings Season

These firms present at least a modest risk/reward profile, but could be preparing for a share price turnaround depending upon how earnings season plays out.

The Guardian - UK

NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss

Pascal Soriot calls for cost-effectiveness thresholds to undergo ‘substantial adjustment based on inflation’

Evening Standard

NHS rollout of new eczema cream could benefit more than 62,000 people in England

Chronic hand eczema causes the hands to become dry, sore, cracked and itchy, making tasks difficult.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Moukoko’s arrival at FC Copenhagen offers a cautionary tale for any wonderkid

Once labelled ‘the biggest talent in the world’, the former Borussia Dortmund forward has endured form fluctuations, controversy and criticism

Louder

"We'd been going down well until that happened": How The Nice offended Leonard Bernstein and the US Embassy

The story of the song that crystallised the burgeoning prog-rock movement and turned The Nice into one of the most controversial bands of the day

The Independent UK

Prostate cancer screenings could save lives but experts warn of major risks

Prostate cancer is the most common cancer among men in the UK, with more than 64,000 diagnoses anually

Evening Standard

Study shows prostate cancer screening can ‘reduce deaths’ as UK scheme assessed

Experts called for a ‘targeted’ screening approach to prevent overdiagnosis.

The Guardian - UK

Prostate cancer drug that can halve death risk to be offered to thousands in England

At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects

The Independent UK

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it

It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients

Evening Standard

Prostate cancer sufferers in ‘postcode lottery’ to get new drug, says charity

It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.